Our Thinking

How big is the market for…?

We often are asked the size of the market for various segments of the bio/pharma contract services industry. In response, we’ve developed a resource page that addresses these questions. It includes sources, and in many cases we’ve added…

Trend Reports

CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance

Our research team crunched the numbers on 2014 drug approvals authorized by FDA’s CDER, CBER, Fast Track and Breakthrough drugs, and selected EMA approved drugs. The bottom line of this report is that…


Follow the Money: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals recently raised almost $367 million in the completion of a secondary public offering. The company depends upon Contract Research Organi-zations to conduct its clinical trials. Contract Development & Manufacturing Organi-zations should also take note that…

Lead Sheet

Real-time Expert BD Intelligence

CROs, CMOs and CDMOs worldwide depend on the PharmSource Lead Sheet for fresh leads, up-to-date contact information and reliable market intelligence. Quickly scout well-targeted new business opportunities. Learn more

Strategic Advantage

Proprietary Global Sourcing Intelligence in an Instant

Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more

Market Intelligence

Aenova Expands Injectables Capacity, Consolidates Network

Aenova has made a significant investment to expand its injectables capacity while consolidating the rest of its manufacturing network.

The company announced the completion of a €6 million ($6.6 million) investment at its injectables facility in Wolfratshausen, Germany. The project provided for…